Skip to content

ICU Acquired Neuromyopathy and Diaphragm Function

Diaphragm Function in Patients Acquired Weakness and Neuromyopathy in ICU: Impact on Weaning and Outcome (DIAPH-WEAK ICU)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01968889
Enrollment
60
Registered
2013-10-24
Start date
2013-05-31
Completion date
2013-11-30
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness Myopathy, Respiratory Paralysis

Keywords

Critical illness neuromyopathy, Diaphragm dysfunction, Mechanical ventilation, Weaning, Ultrasound

Brief summary

Critical illness neuromyopathy is a common disease acquired during ICU stay leading to a deep weakness involving the respiratory muscle work which result in a delayed weaning of mechanical ventilation. The main objective is to quantify the loss of diaphragm function by measuring the diaphragm force (using the non invasive method by phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion) in a selected population of patients with critical illness neuromyopathy (defined as a MRC score \< 48). The second end points are to evaluate its incidence, the consequences on the patients outcome (extubation success or failure; ICU stay) and to evaluate the relations between diaphragm function (twitch airway pressure during airway occlusion, maximal inspiratory pressure and diaphragm thickness evaluated by ultrasound) and peripheral limbs force (evaluated by the Medical Research Council - MRC score).

Detailed description

Diaphragm function will be assessed through phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion (expressed in cmH2O). It will be assessed during a spontaneous breathing trial for each patient with a known critical illness neuromyopathy. The diaphragm (thickness and course) will be studied by ultrasound assessment as well. Peripheral limbs force will be evaluated by the MRC score. A total of 40 analysable patients will be included. All these measurements will be made at the time of the spontaneous breathing trial (SBT) during the weaning phase. No modification of the clinical practices of the care should be modified by the study. The twitch airway pressure during airway occlusion will be assessed at the begining of the SBT. The other measurements will be performed 30 mn after the SBT if this one will be well tolerated. Participants will be followed for the duration of ICU stay.

Interventions

OTHERNon invasive phrenic nerve stimulation

Non invasive phrenic nerve stimulation allowing to measure the twitch airway pressure during airway occlusion

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* MRC score \<48 * ready for weaning from mechanical ventilation

Exclusion criteria

* previous history of neuromyopathy * impossibility to perform a magnetic stimulation * cervical spine injury * bihemispheric or brain stem lesion

Design outcomes

Primary

MeasureTime frameDescription
Twitch tracheal pressure during airway occlusion (expressed in cmH2O)At the begining of the spontaneous breathing trialAccording the standard of care of weaning process; to evaluate the readiness of the patient to be extubated, the setting of the ventilator should be set at 7 cmH20 PRESSURE SUPPORT VENTILATION (PSV) level and zero end expiratory pressure (PEEP=0) during spontaneous mechanical ventilation to mimic the spontaneous breathing trial (SBT).

Secondary

MeasureTime frameDescription
extubation success (defined as no need reintubation during the 48h after extubation)Day 28 after ICU admissionParticipants will be followed until Day 28 after ICU admission.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026